Periodic Reporting for period 1 - STERILISE (Safe sustainable reliable in-office processing of medical waste)
Reporting period: 2015-05-01 to 2015-10-31
The feasibility study objectives included :
a) a risk assessment to quantify and mitigate any project technical, legislative, financial and commercial risks
b) a market study to quantify the global regions that will benefit most from our system based upon their national waste management streams.
c) User Involvement: To engage with medical practices and present the TE 5000 concept as well as offer free testing which will be followed up and analysed for any changes.
d) Develop the IPR strategy: To assess the optimum IPR strategy to best valorise our innovation.
e) Innovation Strategy Development: To build up a roadmap for future innovative developments.
f) Emissions Test: To use an industry recognised test facility and perform an emission and odour test on both the sharps cycle and the non-sharps cycle run on the TE 5000.
g) To collate the information gathered in stage 1 and elaborate the Business Plan.
If the legislation regarding the transportation of medical waste were to change favourably in the future then the potential for the unit finding a market in Europe would increase dramatically. However it is strongly felt that the filtration system of the unit may well have huge potential in other areas- given that it operated so well. The next objective is to explore the potential that this option may present.